Search

everythinglearnresearchcommunity

for

Search:↓

Men with early balding showed higher levels of certain genes linked to hair loss and possibly prostate cancer.

Drugs targeting the Androgen Receptor are effective for treating prostate cancer and other androgen-related conditions.

Nanocarriers with plant extracts show promise for safe and effective hair growth treatment.

Hyperandrogenism is a common hormonal disorder in women, often linked to PCOS.

Androgen suppression therapy (AST) doesn't significantly lower bladder cancer risk, but using finasteride, a type of AST, might decrease the risk. AST also lessens the chance of cancer coming back but doesn't really affect survival rates. More research is needed to understand AST's benefits for different bladder cancers.

Androgen suppression therapy (AST) doesn't significantly lower bladder cancer risk, but using finasteride, a type of AST, might reduce it. AST decreases recurrence-free survival but doesn't affect overall survival or progression-free survival. More research is needed to understand AST's benefits.

Environmental factors and chemicals might affect hormone balance and contribute to common hair loss.

Curcuma aeruginosa Roxb. may help treat hair loss by affecting specific biological pathways.

New biomaterial treatments for baldness show promise, with options depending on patient needs.

Androgenetic alopecia is linked to heart disease, metabolic issues, and mental health problems.

We now understand more about what causes acne and this could lead to better, more personalized treatments.

Different treatments for Hidradenitis suppurativa range from antibiotics and hormonal therapies to surgery, depending on severity.

Minoxidil and Finasteride are effective for male baldness; more research is needed for hair aging treatments.

SARMs may be an effective treatment for a certain type of breast cancer by blocking cancer growth and spread.

Female pattern hair loss is caused by multiple factors and while treatments like topical minoxidil, hormone therapy, and low-level light therapy can help, none can fully cure it.

Light therapy can stimulate hair growth and is more effective when started early, but more research is needed on its long-term effects and optimal use.

The conclusion is that understanding how hair follicle stem cells live or die is important for maintaining healthy tissue and repairing injuries, and could help treat hair loss, but there are still challenges to overcome.

High BMI worsens hair growth in women with PCOS.

Proxalutamide improved recovery, lowered death rates, and reduced hospital stay for COVID-19 patients.

Acne can't be cured but can be managed with treatments like benzoyl peroxide and diet changes; it's costly and can lead to scarring and mental health issues.

The study concluded that similar pathways regulate hair growth in dogs and mice, and these pathways are disrupted in dogs with Alopecia X, affecting stem cells and hormone metabolism.

Hormone therapy for prostate cancer can increase heart risks, especially in men with heart conditions.

Combination therapies for androgenetic alopecia work best but can have significant side effects and costs.

Managing oxidative stress might help treat low testosterone and related chronic diseases in aging men.

Melasma's causes include genetics, sun exposure, hormones, and oxidative stress, and understanding these can help create better treatments.

Drinking a lot of alcohol increases the risk of prostate cancer and can worsen the condition.

New regenerative treatments for hair loss show promise but need more research for confirmation.

Early diagnosis and a combination of treatments, including minoxidil and finasteride, are recommended for managing hair loss in India.

Anti-androgens can help manage some PCOS symptoms better than metformin but are not more effective than placebos or birth control pills for other symptoms.

Advancements in nanoformulations for CRISPR-Cas9 genome editing can respond to specific triggers for controlled gene editing, showing promise in treating incurable diseases, but challenges like precision and system design complexity still need to be addressed.